Mitomycin-C Use and Complications in Ophthalmology
Journal Title: International Journal of Clinical and Experimental Ophthalmology - Year 2017, Vol 1, Issue 1
Abstract
Mitomycin-C, first found its way into ophthalmic use in 1969, in Japan, where recurrent pterygia were successfully treated with the drug which is an antineoplastic / antibiotic agent isolated from the soil bacterium Streptomyces caespitosus [1]. It is an anti-metabolite with anti-proliferative effect on cells showing the highest rate of mitosis by inhibiting DNA synthesis and interferes with RNA transcription and protein synthesis [2].
Authors and Affiliations
T Cumurcu
Theory and Experiments. (+) Add Reading Glasses to Prevent Myopia
Basic control theory equations are developed showing conventional exponential system response of refraction vs. time R (t) with a characteristic system time constant, in response to a step change of near work environment...
Efficacy of early Hyperbaric Oxygen Therapy in Central Retinal Artery Occlusion
A 60-year-old woman had central retinal artery occlusion (CRAO) presented to the ophthalmology department with a sudden, painless loss of vision. Her initial visual acuity was light perception and she treated with hyperb...
Ocular changes and disorders associated with Obesity
Obesity is a chronic and metabolic disease with a high increasing prevalence worldwide. It has multifactorial pathogenesis including genetic and behavioral factors [1-5]. Overweight and obesity have been defined and clas...
Chronic recurrent bilateral granulomatous iridocyclitis in an 18-year-old woman
A case of recurrent tuberculosis-related uveitis in a young female patient of North African origin.
Place of beta-radiation in the etiology and treatment of cataract
Among eye diseases, cataract is the most commonly encountered lens disease and the leading cause of reduced vision. Cataract caused by radiation develops due to neck & head, central nervous system tumors, eye localized t...